SLC45A2 and hepatocellular carcinoma: Interestingly, in 2 patients with HCC, SLC45A2–AMACR emerged as a new transcript in the post-treatment serum, while in 8, ZMPSTE24–ZMYM4 emerged as a new transcript after treatment.